Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
278 Leser
Artikel bewerten:
(1)

Elite Capital & Co. Limited: Government Future Financing 2030 Program visits the Advisory Commission to the Presidency of the Council of Ministers

Finanznachrichten News

BAGHDAD, July 25, 2024 (GLOBE NEWSWIRE) -- Mr. George Matharu, President of Elite Capital & Co. Limited, announced today that Dr. Faisal Khazaal, Chairman of the Government Future Financing 2030 Program, which is managed exclusively by Elite Capital & Co. Limited, and the accompanying delegation, has visited Dr. Abdulkareem Al Faisal, the Chairman of the Advisory Commission to the Presidency of the Council of Ministers in the Republic of Iraq, to exchange views in examining ways to promote national and green projects in this important region.

News-July24-2024-1200

"The visit of the Government Future Financing 2030 Program's delegation yesterday, Wednesday, July 24, 2024, was excellent, as the delegation explained the possibility of cooperation to finance national and green projects for the Republic of Iraq without affecting its credit rating, as well as finding solutions to reduce the financial cost very significantly on the future aspirations of the Iraqi development plan to achieve self-sufficiency and economic sustainability," Mr. George Matharu said.

The Advisory Commission to the Presidency of the Council of Ministers in Iraq plays a crucial role in providing strategic advice and recommendations to the Prime Minister and the Council of Ministers. This commission is involved in various aspects of governance, including policy formulation, economic planning, and administrative reforms.

The Council of Ministers, led by Prime Minister Mohammed Shia' Al-Sudani, is the principal executive body of the Iraqi government. The commission's work supports the Council in making informed decisions that impact the country's development and governance.

"The Republic of Iraq is located in a strategic and vital spot on the continent of Asia and the Middle East and has great relations with many countries of the world. The current government is working diligently and sincerely to develop this country, which is expected to play an important role in the global economic movement within the next few years," Mr. George Matharu said.

Elite Capital & Co. Limited is a Financial Management company that provides project-related services, including Management, Consultancy, and Funding, particularly for large infrastructure and mega commercial projects.

Elite Capital & Co. Limited offers a wealth of experience in Banking and Financial transactions and has a range of specialized advisory services for private clients, medium and large corporations as well as governments. It is also the exclusive manager of the Government Future Financing 2030 Program®.

Mr. George Matharu, MBA. concluded his statement by saying, "The Government Future Financing 2030 Program looks forward to fruitful cooperation to participate in supporting the Iraqi economy, especially finding alternative solutions to reduce the financial cost of national and green projects in Iraq's future development plan."

Contact Details -

Elite Capital & Co. Limited
33 St. James Square
London, SW1Y4JS
United Kingdom

Telephone: +44 (0) 203 709 5060
SWIFT Code: ELCTGB21
LEI Code: 254900NNN237BBHG7S26

Website: ec.uk.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2e87acae-3bad-4685-acbe-a38d58bd54ed


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.